Menu

Blog

Jan 23, 2024

New study reveals effective strategies against drug resistance in hospital-acquired pneumonia treatment

Posted by in category: biotech/medical

https://www.news-medical.net/news/20240123/New-study-reveals…tment.aspx ASMicrobiology


In a recent study published in the American Society for Microbiology, researchers developed a novel rabbit infection model to investigate meropenem’s resistance development potential and antibacterial efficacy.

Study: Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa. Image Credit: Sam Rana/Shutterstock.com.

Background

Meropenem is an antibacterial drug representing the current gold standard in hospital-acquired pneumonia (HAP) care.

Comments are closed.